Inclusion Criteria:~* Diagnosis of probable Alzheimer Disease (AD), with Mini Mental State Examination (MMSE)
score of 16-26, and brain magnetic resonance imaging (MRI) consistent with the diagnosis of AD~* Concurrent use
of cholinesterase inhibitor or memantine allowed, if stable~* Caregiver will participate and be able to attend
clinic visits with patient~
